Latest Articles

Publication Date
All News Scientific
Vicky Pattison: Doctors lacked empathy when I suffered with PMDD - The Independent

Vicky Pattison: Doctors lacked empathy when I suffered with PMDD The Independent

Published: Dec. 11, 2024, 11:40 a.m.
Read Full Article
Burjeel-Aasandha Partnership Brings Complex Care Closer to Maldivians, Boosts Medical Tourism in Abu Dhabi - Emirates 24|7

Burjeel-Aasandha Partnership Brings Complex Care Closer to Maldivians, Boosts Medical Tourism in Abu Dhabi Emirates 24|7

Published: Dec. 11, 2024, 9:55 a.m.
Read Full Article
Frankston Hospital Redevelopment Hits Major Milestone 11 December - Mirage News

Frankston Hospital Redevelopment Hits Major Milestone 11 December Mirage News

Published: Dec. 10, 2024, 11:36 p.m.
Read Full Article
Addressing mental health risks in endometriosis patients - Contemporary Obgyn

Addressing mental health risks in endometriosis patients Contemporary Obgyn

Published: Dec. 10, 2024, 10:07 p.m.
Read Full Article
Female-Specific Factors Don’t Enhance Common Risk Calculators - TCTMD

Female-Specific Factors Don’t Enhance Common Risk Calculators TCTMD

Published: Dec. 10, 2024, 9 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
Got A Test Tomorrow? Take A Brisk Walk Now To Boost Your Memory - Medical Daily

Got A Test Tomorrow? Take A Brisk Walk Now To Boost Your Memory Medical Daily

Published: Dec. 10, 2024, 9:08 a.m.
Read Full Article
GSK Korea expands indication for Jemperli in endometrial cancer treatment - KBR

GSK Korea expands indication for Jemperli in endometrial cancer treatment KBR

Published: Dec. 10, 2024, 3:13 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!